Cadrenal Therapeutics, Inc. Common StockCVKDNASDAQ
Loading
Year-over-year operating income growth rate
Latest
26.79%
↑ 162% vs avg
Percentile
P93
Near historical high
Streak
1 qtr
Consecutive growthAccelerating
Average
-43.00%
Historical baseline
| Period | Value |
|---|---|
| Q3 2025 | 26.79% |
| Q2 2025 | 4.93% |
| Q1 2025 | 8.19% |
| Q4 2024 | -73.92% |
| Q3 2024 | 0.27% |
| Q2 2024 | -40.50% |
| Q1 2024 | -38.91% |
| Q4 2023 | -10.61% |
| Q3 2023 | -11.34% |
| Q2 2023 | 75.57% |
| Q1 2023 | -290.37% |
| Q4 2022 | -10.61% |
| Q3 2022 | -101.68% |
| Q2 2022 | -182.87% |
| Q1 2022 | 0.00% |